Holen Sie sich die Stockscreener-App
8.84
4.54%
-0.42
Vorhandelsmarkt:
8.90
0.06
+0.68%
Schlusskurs vom Vortag:
$9.26
Offen:
$9.26
24-Stunden-Volumen:
5.59M
Relative Volume:
0.99
Marktkapitalisierung:
$2.30B
Einnahmen:
$6.22B
Nettoeinkommen (Verlust:
$187.00M
KGV:
12.34
EPS:
0.7166
Netto-Cashflow:
$508.00M
1W Leistung:
+1.61%
1M Leistung:
+46.60%
6M Leistung:
-2.00%
1J Leistung:
-16.84%
1-Tages-Spanne:
$8.785
$9.46
1-Wochen-Bereich:
$8.335
$9.83
52-Wochen-Spanne:
$5.69
$13.24
Organon Co Stock (OGN) Company Profile
Firmenname
Organon Co
Sektor
Telefon
551-430-6000
Adresse
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, AZN, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
8.84 | 2.30B | 6.22B | 187.00M | 508.00M | 0.7166 |
LLY
Lilly Eli Co
|
903.02 | 806.72B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
226.16 | 544.73B | 96.36B | 21.04B | 19.70B | 8.6488 |
ABBV
Abbvie Inc
|
205.12 | 362.81B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
195.78 | 303.62B | 58.80B | 10.24B | 8.98B | 3.2788 |
NVS
Novartis Ag Adr
|
147.97 | 282.35B | 54.72B | 14.02B | 15.32B | 7.1855 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-10-27 | Herabstufung | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-09-06 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-21 | Eingeleitet | Barclays | Overweight |
| 2023-03-16 | Eingeleitet | Raymond James | Outperform |
| 2022-10-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-01 | Eingeleitet | BofA Securities | Buy |
| 2021-07-22 | Eingeleitet | Citigroup | Buy |
| 2021-06-15 | Eingeleitet | JP Morgan | Neutral |
| 2021-06-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Organon Co Aktie (OGN) Neueste Nachrichten
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
What does Sun Pharma gain from its $12-billion Organon bid? - MSN
Organon (OGN) Is Up 8.4% After VTAMA Wins Key Steroid-Free Role In New Pediatric Guidelines - simplywall.st
Why Organon (OGN) Drew Buyout Buzz After a Sharp Repricing - Yahoo Finance
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility - MSN
Organon & Co (OGN) Stock Price Quote Today & Current Price Chart - Capital.com
Organon rises as Sun Pharma said to near $12B buyout deal - MSN
This women’s health company is drawing takeover interest. The stock is soaring. - MSN
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN
Organon & Co. Soars 17.92% to Hit Intraday High of USD 6.96 - Markets Mojo
Organon gains as Sun Pharma, Grünenthal said to seek takeover deals - MSN
Organon (OGN) stock drops despite market gains: Important facts to note - MSN
Sun Pharma preps for Organon bid - ifr-logo
Healthcare Sector Analysis: Organon & Co. (OGN) Leads with Low F - GuruFocus
Organon (OGN) rises higher than market: Key facts - MSN
Organon (OGN) Rises Higher Than Market: Key Facts - Yahoo Finance
Organon (OGN) Shares Rise as Sun Pharma and Grünenthal Eye Acqui - GuruFocus
Organon & Co. (OGN) Stock Rises 4% to $9.6 - AlphaStreet
Organon & Co. (NYSE:OGN) Shares Gap UpTime to Buy? - MarketBeat
Organon gets buyout interest from Sun Pharma, Grünenthal (OGN) - Seeking Alpha
Press Release: Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 - 富途牛牛
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 - Bluefield Daily Telegraph
Organon & Co. (NYSE:OGN) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Why Organon (OGN) Is Surging as Buyout Interest Gains Traction - Insider Monkey
Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon - Bloomberg
AAD recommends Organon’s VTAMA cream for pediatric atopic dermatitis - Investing.com
Only steroid-free cream AAD backs for all child eczema severities - Stock Titan
Massachusetts Financial Services Co. MA Cuts Stock Holdings in Organon & Co. $OGN - MarketBeat
Sun Pharma Faces Fresh Organon Acquisition Reports After Official Denial - scanx.trade
Organon & Co. Experiences Evaluation Revision Amidst Mixed Market Indicators and Volatility - Markets Mojo
Organon (OGN) climbs 39% on $12-billion merger buzz - MSN
Organon & Co. (NYSE:OGN) Q4 2025 earnings call transcript - MSN
Organon & Co. Shares Drop 6.4% as Analysts Forecast Weak Growth - National Today
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
3 Reasons to Avoid OGN and 1 Stock to Buy Instead - Yahoo Finance UK
Organon & Co. (NYSE:OGN) Shares Down 6.4%Time to Sell? - MarketBeat
Unusually active option classes on open April 13th - TipRanks
Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN) - Seeking Alpha
Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com
Sun Pharma’s Reported US$12b Bid Recasts Organon’s Risk Reward Profile - Sahm
American pharmaceutical MSD receiving billions in tax benefits in the Netherlands - NL Times
EBIT per share of Organon & Co. – SWB:7XP - TradingView — Track All Markets
Is Organon (OGN) Now An Opportunity After Its Recent Share Price Surge? - Yahoo Finance
Buy or Sell Organon Stock in 2026? Takeover Buzz Lifts Shares 28% as Analysts Stay Cautious - International Business Times Australia
Institutional Money Floods Organon as Analysts Warn and Charts Conflicted - Bitget
Organon (OGN) Climbs 39% on $12-Billion Merger Buzz - Insider Monkey
Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more - Seeking Alpha
Avoiding Lag: Real-Time Signals in (OGN) Movement - Stock Traders Daily
Organon Shares Soar as Sun Pharmaceutical Eyes $12B Deal - timothysykes.com
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid - Yahoo Finance
Morgan Stanley Reaffirms Their Hold Rating on Organon (OGN) - The Globe and Mail
Finanzdaten der Organon Co-Aktie (OGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):